BIOVERATIV USA INC has a total of 91 patent applications. It decreased the IP activity by 13.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are THERAMAB LLC, SALPEP BIOTECHNOLOGY INC and NEXVET AUSTRALIA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 | |
#2 | United States | 10 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Brazil | 5 | |
#5 | China | 5 | |
#6 | Israel | 5 | |
#7 | Republic of Korea | 5 | |
#8 | Canada | 4 | |
#9 | Japan | 4 | |
#10 | Mexico | 4 | |
#11 | Singapore | 4 | |
#12 | Chile | 3 | |
#13 | Colombia | 3 | |
#14 | Costa Rica | 3 | |
#15 | Hong Kong | 3 | |
#16 | Taiwan | 3 | |
#17 | WIPO (World Intellectual Property Organization) | 3 | |
#18 | Dominican Republic | 2 | |
#19 | Ecuador | 2 | |
#20 | Peru | 2 | |
#21 | Argentina | 1 | |
#22 | Philippines | 1 | |
#23 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Enzymes | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Panicker Sandip | 69 |
#2 | Parry Graham | 69 |
#3 | Stagliano Nancy E | 33 |
#4 | Van Vlasselaer Peter | 22 |
#5 | Graham Parry | 15 |
#6 | Sandip Panicker | 15 |
#7 | Christopherson Karen Sue | 10 |
#8 | Byun Tony Sangyoung | 10 |
#9 | Nikitin Pavel A | 7 |
#10 | Nancy E Stagliano | 7 |
Publication | Filing date | Title |
---|---|---|
CN111527105A | Methods of inducing complement activity | |
BR112019018950A2 | methods for treating complement-mediated diseases and disorders | |
SG11201903012RA | Anti-c1s antibodies and methods of use thereof | |
KR20190003951A | Anti-complement factor BB antibodies and uses thereof | |
CN108348600A | The method for treating autoimmune disorder and isoimmunization illness |